• Citer

The European ankylosing spondylitis infliximab cohort (EASIC): A European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab

par Heldmann, Frank;Braun, Jürgen;Brandt, Jan;van der Horst-Bruinsma, Irene I.E.;Landewe, Robert;Sieper, Joachim;Burmester, Gerd G.R.;Van Den Bosch, Filip;de Vlam, Kurt;Geusens, Piet P M M P.;Gaston, Hill;Schewe, Stefan;Appelboom, Thierry ;Emery, Paul;Dougados, Maxime;Leirisalo-Repo, Marjatta;Bréban, Maxime;Listing, Joachim
Référence Clinical and Experimental Rheumatology, 29, 4, page (672-680)
Publication Publié, 2011-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	The European ankylosing spondylitis infliximab cohort (EASIC): A European multicentre study of long-term outcomes in patients with ankylosing spondylitis treated with infliximab
Auteur:	Heldmann, Frank; Braun, Jürgen; Brandt, Jan; van der Horst-Bruinsma, Irene I.E.; Landewe, Robert; Sieper, Joachim; Burmester, Gerd G.R.; Van Den Bosch, Filip; de Vlam, Kurt; Geusens, Piet P M M P.; Gaston, Hill; Schewe, Stefan; Appelboom, Thierry; Emery, Paul; Dougados, Maxime; Leirisalo-Repo, Marjatta; Bréban, Maxime; Listing, Joachim
Informations sur la publication:	Clinical and Experimental Rheumatology, 29, 4, page (672-680)
Statut de publication:	Publié, 2011-07
Sujet CREF:	Allergie et immunopathologie
	Rhumatologie
	Immunologie
Mots-clés:	Ankylosing spondylitis
	Anti-TNF
	Infliximab
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0392-856X
	info:scp/80055097919
	info:pmid/21906431